Aptahem AB (publ) (NGM:APTA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.095
-0.065 (-5.60%)
At close: Jul 18, 2025

Aptahem AB Company Description

Aptahem AB (publ), a biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

The company’s lead products candidate is Apta-1, which is in preclinical stage to prevent the onset of life-threatening organ and tissue damage in sepsis patients.

It has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children’s Research Institute, and University Health Network.

Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

Aptahem AB (publ)
CountrySweden
Founded2014
IndustryBiotechnology
SectorHealthcare
Employees4
CEOMikael Lindstam

Contact Details

Address:
Norra Vallgatan 58
Malmö, 211 22
Sweden
Phone46 7 66 02 01 99
Websiteaptahem.com

Stock Details

Ticker SymbolAPTA
ExchangeNordic Growth Market
Fiscal YearJanuary - December
Reporting CurrencySEK
SIC Code2836

Key Executives

NamePosition
Mikael LindstamCo-Founder and Chief Executive Officer
Dr. Bert JunnoCo-Founder and Chairman
Dr. Kjell G. StenbergChief Marketing Officer and Pres
Luiza JedlinaCo-Founder and CSO
Ola SkanungChief Financial Officer
Maria EkbladChief Operating Officer
Ulf Bjorklund M.Sc.Senior Executive Advisor
Ingela HallbergChief Medical Officer